Medical Rationale
The gut-brain axis connects central anxiety circuitry (amygdala, hypothalamus) to the enteric nervous system through vagal afferents, the HPA axis, and autonomic pathways. Chronic anxiety produces sustained sympathetic activation that alters gastrointestinal motility, increases visceral hypersensitivity, and disrupts the intestinal epithelial barrier. Elevated cortisol from chronic anxiety increases intestinal permeability ("leaky gut"), allowing bacterial translocation and mucosal immune activation that drives IBS symptomatology. Anxiety also alters the gut microbiome composition, reducing Lactobacillus and Bifidobacterium species while promoting pro-inflammatory Proteobacteria — dysbiosis that perpetuates visceral hypersensitivity and altered motility through local serotonin signaling disruption.
Key Studies
Mayer EA et al. (2015) J Clin Invest (gut-brain axis in IBS — pathophysiology); Fond G et al. (2014) World J Gastroenterol (anxiety disorders and IBS — systematic review and meta-analysis).
Filing Tips
Gastroenterology records documenting IBS diagnosis (Rome IV criteria) with onset after established service-connected anxiety disorder. Stool studies ruling out inflammatory bowel disease, celiac disease, and infection. A gastroenterologist or psychiatrist nexus letter addressing the gut-brain axis mechanism. Document the temporal relationship between anxiety exacerbations and GI symptom flares. File under DC 7319 (irritable colon syndrome) — severe IBS with alternating diarrhea/constipation warrants a 30% rating.